We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+6.63%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$82.8B
AUM Growth
+$1.44B
Cap. Flow
-$2.02B
Cap. Flow %
-2.43%
Top 10 Hldgs %
16.17%
Holding
1,933
New
90
Increased
882
Reduced
857
Closed
96

Top Buys

Rank Stock Value
1
EBAY icon
eBay
EBAY
+$366M
2
KMX icon
CarMax
KMX
+$273M
3
ORLY icon
O'Reilly Automotive
ORLY
+$240M
4
MSI icon
Motorola Solutions
MSI
+$212M
5
BABA icon
Alibaba
BABA
+$201M

Top Sells

Rank Stock Value
1
NKTR icon
Nektar Therapeutics
NKTR
+$401M
2
FTI icon
TechnipFMC
FTI
+$399M
3
AZO icon
AutoZone
AZO
+$327M
4
CSCO icon
Cisco
CSCO
+$232M
5
NTES icon
NetEase
NTES
+$181M

Sector Composition

Rank Sector Weight
1 Financials 15.41%
2 Consumer Discretionary 14.11%
3 Energy 13.48%
4 Healthcare 12.91%
5 Technology 11.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APTV icon
151
Aptiv
APTV
$12B
$136M 0.16%
1,608,788
-495,627
-24% -$47.2M
DVA icon
152
DaVita
DVA
$15.1B
$135M 0.16%
1,873,918
+1,839,168
+5,293% +$113M
IONS icon
153
Ionis Pharmaceuticals
IONS
$9.35B
$135M 0.16%
2,689,981
-18,426
-0.7% -$1.01M
PF
154
DELISTED
Pinnacle Foods, Inc.
PF
$134M 0.16%
2,248,753
-203,302
-8% -$11.5M
WMT icon
155
Walmart Inc
WMT
$871B
$133M 0.16%
4,054,188
-1,738,356
-30% -$53.2M
MDT icon
156
Medtronic
MDT
$107B
$131M 0.16%
1,627,053
-83,313
-5% -$6.67M
VC icon
157
Visteon
VC
$2.77B
$131M 0.16%
1,049,828
+38,646
+4% +$4.9M
VMC icon
158
Vulcan Materials
VMC
$36.3B
$129M 0.16%
1,005,445
-128,345
-11% -$15.7M
NBL
159
DELISTED
Noble Energy, Inc.
NBL
$128M 0.15%
4,399,822
+302,201
+7% +$8.27M
TXN icon
160
Texas Instruments
TXN
$255B
$125M 0.15%
1,200,252
+6,187
+0.5% +$602K
TAP icon
161
Molson Coors Class B
TAP
$7.68B
$125M 0.15%
1,517,875
-426,404
-22% -$34.5M
BPMC
162
DELISTED
Blueprint Medicines
BPMC
$123M 0.15%
1,632,006
+126,752
+8% +$8.92M
GMLP
163
DELISTED
Golar LNG Partners LP
GMLP
$122M 0.15%
5,344,183
-60,018
-1% -$1.32M
LH icon
164
Labcorp
LH
$24.3B
$121M 0.15%
880,278
-103,133
-10% -$13.6M
HBI
165
DELISTED
Hanesbrands
HBI
$120M 0.15%
5,756,405
-2,298,002
-29% -$49.1M
BMRN icon
166
BioMarin Pharmaceuticals
BMRN
$11.5B
$117M 0.14%
1,317,134
-31,239
-2% -$2.72M
MANH icon
167
Manhattan Associates
MANH
$8.97B
$117M 0.14%
2,369,894
-62,676
-3% -$2.81M
OKE icon
168
Oneok
OKE
$58.7B
$117M 0.14%
2,187,608
-1,174,232
-35% -$62.7M
ABT icon
169
Abbott
ABT
$180B
$115M 0.14%
2,018,836
-593,860
-23% -$32.9M
JNJ icon
170
Johnson & Johnson
JNJ
$635B
$115M 0.14%
824,094
-33,075
-4% -$4.61M
AZO icon
171
AutoZone
AZO
$48.3B
$115M 0.14%
161,510
-512,191
-76% -$327M
ALK icon
172
Alaska Air
ALK
$5.15B
$115M 0.14%
1,560,244
+1,547,811
+12,449% +$110M
HUM icon
173
Humana
HUM
$46.7B
$115M 0.14%
461,589
+1,771
+0.4% +$437K
AIG icon
174
American International
AIG
$41.9B
$113M 0.14%
1,895,294
-651,263
-26% -$40M
KDP icon
175
Keurig Dr Pepper
KDP
$40.4B
$110M 0.13%
1,133,550
+58,872
+5% +$5.28M
5 6
7
8 9

Similar funds

TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
SBAM
Santa Barbara Asset Management Los Angeles, California $6.43B AUM 10.99% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
SA
SQ Advisors Naples, Florida $1.32B AUM 10.3% 1-Year Est. Return
WF
WealthTrust Fairport Cleveland, Ohio $1.06B AUM 3.47% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

OppenheimerFunds's Q4 2017 Portfolio in Review

As of Q4 2017, OppenheimerFunds held 1,933 positions worth $82.8B, up 1.8% from $81.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

OppenheimerFunds's Q4 2017 filing shows 90 new, 882 increased, 857 reduced and 96 closed positions. Its largest new stake was Nebius Group N.V.: 5,110,710 shares worth $167M. The largest sale was Nektar Therapeutics, an estimated $401M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.

  • OppenheimerFunds's largest Q4 2017 buy was Nebius Group N.V.: 5,110,710 shares worth $167M.
  • OppenheimerFunds added most to eBay in Q4 2017, an estimated $366M increase.
  • OppenheimerFunds's biggest Q4 2017 reduction was Nektar Therapeutics, cutting an estimated $401M.
  • OppenheimerFunds fully exited NetEase in Q4 2017, selling an estimated $181M.
  • OppenheimerFunds's ten largest holdings make up 16% of its $82.8B portfolio in Q4 2017.
  • OppenheimerFunds opened 90 new positions and closed 96 in Q4 2017.
  • OppenheimerFunds's portfolio value rose 1.8% quarter-over-quarter to $82.8B.

Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.